Antoni, A.; Wedrich, L.; Schauperl, M.; Höchtl-Lee, L.; Sigmund, I.K.; Gregori, M.; Leitgeb, J.; Schwendenwein, E.; Hajdu, S.
Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer? J. Clin. Med. 2022, 11, 6268.
https://doi.org/10.3390/jcm11216268
AMA Style
Antoni A, Wedrich L, Schauperl M, Höchtl-Lee L, Sigmund IK, Gregori M, Leitgeb J, Schwendenwein E, Hajdu S.
Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer? Journal of Clinical Medicine. 2022; 11(21):6268.
https://doi.org/10.3390/jcm11216268
Chicago/Turabian Style
Antoni, Anna, Lukas Wedrich, Martin Schauperl, Leonard Höchtl-Lee, Irene K. Sigmund, Markus Gregori, Johannes Leitgeb, Elisabeth Schwendenwein, and Stefan Hajdu.
2022. "Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?" Journal of Clinical Medicine 11, no. 21: 6268.
https://doi.org/10.3390/jcm11216268
APA Style
Antoni, A., Wedrich, L., Schauperl, M., Höchtl-Lee, L., Sigmund, I. K., Gregori, M., Leitgeb, J., Schwendenwein, E., & Hajdu, S.
(2022). Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer? Journal of Clinical Medicine, 11(21), 6268.
https://doi.org/10.3390/jcm11216268